US 12,232,736 B2
Occlusive medical device
Joshua Mark Inouye, Maple Grove, MN (US); David John Onushko, Minneapolis, MN (US); Dennis A. Peiffer, Brooklyn Park, MN (US); and James M. Anderson, Corcoran, MN (US)
Assigned to Boston Scientific Scimed, Inc, Maple Grove, MN (US)
Filed by BOSTON SCIENTIFIC SCIMED, INC., Maple Grove, MN (US)
Filed on Jun. 3, 2022, as Appl. No. 17/831,663.
Application 17/831,663 is a continuation of application No. 16/502,190, filed on Jul. 3, 2019, granted, now 11,382,635.
Claims priority of provisional application 62/694,731, filed on Jul. 6, 2018.
Prior Publication US 2022/0313271 A1, Oct. 6, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/12 (2006.01); A61B 17/00 (2006.01)
CPC A61B 17/12122 (2013.01) [A61B 17/12172 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00579 (2013.01); A61B 2017/00632 (2013.01); A61B 2017/00867 (2013.01)] 14 Claims
OG exemplary drawing
 
1. A method of manufacturing an occlusive device within the left atrial appendage, the method comprising:
securing a fixation member to an expandable framework, wherein the fixation member includes a first engagement portion, a medial portion and an anchor portion, and securing the fixation member to the expandable framework positions the fixation member such that the medial portion extends along an inner surface of the expandable framework;
wherein the expandable framework is configured to shift between a first configuration and an expanded configuration;
wherein the anchor portion extends away from an outer surface of the expandable framework.